Shigella lipopolysaccharide antibodies in pediatric populations
- PMID: 8584312
- DOI: 10.1097/00006454-199510000-00008
Shigella lipopolysaccharide antibodies in pediatric populations
Abstract
Shigellosis is the most common cause of bacterial dysentery. To study the specific immunity to the two major groups causing shigellosis, we assayed antibodies to lipopolysaccharide (LPS) by enzyme-linked immunoadsorbent assay to both Shigella sonnei and Shigella flexneri 2a serotypes in the following populations: (1) women immediately after delivery and their infants to assess the transfer of passive immunity by placenta and the presence of secretory antibodies in breast milk; (2) children of different ages; and (3) the kinetics of antibody production in pediatric patients, who had culture-proved shigellosis. The sera of these women showed variable concentrations of antibodies of all three isotypes to LPS of S. sonnei and S. flexneri 2a. These serotype-specific antibodies were not cross-reactive. Transfer of IgG anti-LPS across the placenta was significantly correlated with concentration of the specific antibody in the mother (S. sonnei, r = 0.96; S. flexneri, r = 0.84). Varying concentrations of anti-LPS IgA were present in colostrum, which was correlated with serum anti-LPS IgA titers in the case of S. sonnei (r = 0.44; P < 0.05) but not S. flexneri (r = 0.17). Healthy children between the ages of 6 months and 4 years in our population had undetectable or relatively low titers of anti-S. sonnei IgG. More children had detectable antibody titers to S. flexneri 2a than to S. sonnei. The relatively high concentrations of these natural antibodies are particularly noteworthy because there is a far lower incidence (< 10% of patients) with S. flexneri than with S. sonnei disease in this population.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.PLoS One. 2021 May 27;16(5):e0252222. doi: 10.1371/journal.pone.0252222. eCollection 2021. PLoS One. 2021. PMID: 34043697 Free PMC article.
-
Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.Vaccine. 1999 Aug 6;17(23-24):3109-15. doi: 10.1016/s0264-410x(99)00136-x. Vaccine. 1999. PMID: 10462247 Clinical Trial.
-
Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.Clin Diagn Lab Immunol. 1996 Jul;3(4):451-5. doi: 10.1128/cdli.3.4.451-455.1996. Clin Diagn Lab Immunol. 1996. PMID: 8807212 Free PMC article.
-
[New directions in the study of immunity in dysentery].Zh Mikrobiol Epidemiol Immunobiol. 1983 Apr;(4):6-12. Zh Mikrobiol Epidemiol Immunobiol. 1983. PMID: 6346759 Review. Russian. No abstract available.
-
Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays.Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S231-7. doi: 10.1093/clinids/13.supplement_4.s231. Rev Infect Dis. 1991. PMID: 2047643 Review.
Cited by
-
Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel.Infect Immun. 2001 Mar;69(3):1351-7. doi: 10.1128/IAI.69.3.1351-1357.2001. Infect Immun. 2001. PMID: 11179298 Free PMC article. Clinical Trial.
-
O-specific [corrected] polysaccharide conjugate vaccine-induced [corrected] antibodies prevent invasion of Shigella into Caco-2 cells and may be curative.Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2396-401. doi: 10.1073/pnas.0610833104. Epub 2007 Feb 7. Proc Natl Acad Sci U S A. 2007. PMID: 17287349 Free PMC article. Clinical Trial.
-
Detoxified O-Specific Polysaccharide (O-SP)-Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene.Vaccines (Basel). 2022 Apr 24;10(5):675. doi: 10.3390/vaccines10050675. Vaccines (Basel). 2022. PMID: 35632431 Free PMC article. Review.
-
Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis.Front Immunol. 2021 Oct 15;12:725129. doi: 10.3389/fimmu.2021.725129. eCollection 2021. Front Immunol. 2021. PMID: 34721387 Free PMC article.
-
Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.PLoS One. 2021 May 27;16(5):e0252222. doi: 10.1371/journal.pone.0252222. eCollection 2021. PLoS One. 2021. PMID: 34043697 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous